Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission

European Journal of Clinical Pharmacology

Volumn 70, Issue 3, 2014, Pages 361-367

  Pedrós, Consuelo ^a,b   Quintana, Beatriz ^a,b   Rebolledo, Mireia ^a,b   Porta, Núria ^b   Vallano, Antoni ^a,b,c   Arnau, Josep Maria ^a,b,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adverse drug reaction reporting systems; Drug toxicity; Hospitalization; Pharmacovigilance; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POLYPHARMACY; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84894498415     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1630-5     Document Type: Article

References (47)

1. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 279:1200-1205
2. Beijer HJM, de Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24:46-54
3. Kongkaew C, Noyce PR, Ashcroft DM (2008) Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 42:1017-1025
4. Leendertse AJ, Visser D, Egberts ACG, van den Bemt PMLA (2010) The relationship between study characteristics and the prevalence of medication-related hospitalizations. Drug Saf 33:233-244
5. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255-1259
6. Commission Directive 2010/84/EU of the European Parliament and the Council of 15 December 2010 amending as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union 31.12.2010: L348/74-L348/99. http://ec.europa.eu/health/files/eudralex/vol-1/dir-2010-84/dir-2010-84-en.pdf. Accessed 17 September 2013
7. Real Decreto 1344/2007, de 11 de octubre, por el que se regula la farmacovigilancia de medicamentos de uso humano. Boletín Oficial de Estado 1/11/2007: 44631-4460. http://www.boe.es/boe/dias/2007/11/01/pdfs/A44631- 44640.pdf. Accessed 17 September 2013
8. Meyboom RHB, Royer RJ (1992) Causality classification at pharmacovigilance centres in the European Community. Pharmacoepidemiol Drug Saf 1:87-97
9. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. The Anatomical Therapeutic Chemical (ATC) classification system. http://www.whocc.no. Accessed 17 September 2013
10. Gruchalla RS (2000) Clinical assessment of drug-induced disease. Lancet 356:1505-1511
11. Ibañez L, Laporte J-R, Carné X (1991) Adverse drug reactions leading to hospital admissions. Drug Saf 6:450-459
12. Garijo B, de Abajo FJ, Castro MA, Lopo CR, Carcas A, Frías J (1991) Hospitalizaciones motivadas por fármacos: un estudio prospectivo. Rev Clin Esp 188:7-12
13. Martín MT, Codina C, Tuset M, Carné X, Nogué S, Ribas J (2002) Problemas relacionados con la medicación como causa de ingreso hospitalario. Med Clin (Barc) 118:205-210
14. Routledge PA, O'Mahony MS, Woodhouse KW (2003) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57:121-126
15. Davies EC, Green CF, Mottram DR et al (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2:79-87
16. Ruiter R, Visser LE, Rodenburg EM, Trifirò G, Ziere G, Stricker BH (2012) Adverse drug reaction-related hospitalizations in persons aged 55 years and over. A population-based study in the Netherlands. Drugs Aging 29:225-232
17. Pouyanne P, Haramburu F, Imbs JL, Bégaud B, for the French Pharmacovigilance Centres (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. Br Med J 320:1036
18. Van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJLHJ, Verhamme KMC, Stricker BHCH, Sturkenboom MCJM (2008) Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 17:365-371
19. Alexopoulou A, Dourakis SP, Mantzoukis D, Pitsariotis T, Kandyli A, Deutsch M, Archimandritis AJ (2008) Adverse drug reactions as a cause of hospital admission: a 6-month experience in a single center in Greece. Eur J Intern Med 19:505-510
20. Leendertse AJ, Egberts ACG, Stoker LJ, van den Bemt PMLA, for the HARM Study Group (2008) Frequency of and risk factors for presentable medication-related hospital admissions in the Netherlands. Arch Intern Med 168:1890-1896
21. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962-1968
22. Caamaño F, Pedone C, Zuccalà G, Carbonin P (2005) Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in elderly population. Arch Gerontol Geriatr 40:45-52
23. Moore N, Lecointre D, Noblet C, Mabille M (1998) Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 45:301-308
24. Von Euler M, Eliasson E, Öhlén G, Bergman U (2006) Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 15:179-184
25. Brvar M, Fokter N, Bunc M, Mozina M (2009) The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department speciality. BMC Clin Pharmacol 9:8
26. Ahern F, Sahm LJ, Lynch D, McCarthy S (2013) Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study. Emerg Med J. doi: 10.1136/emermed-2012-201945
27. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J 329:15-19
28. Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A, Dahlqvuist R (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 11:65-72
29. Olivier P, Boulbés O, Tubery M, Lauque D, Montastruc J-L, Lapeyre-Mestre M (2002) Assessing the feasibility of using and adverse drug reaction preventability scale in clinical practice. A study in a French emergency department. Drug Saf 25:1036-1044
30. Hopf Y, Watson M, Williams D (2008) Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 30:854-862
31. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B (2000) Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 56:181-186
32. Fattinger K, Roos M, Vergères P, Holenstein C, Kind B, Masche U, Stocker DN, Braunschweig S, Kullak-Ublick GA, Galeazzsi RL, Follath F, Gasser T, Meier PJ (2000) Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 49:158-167
33. Zopf Y, Rabe C, Neubert A, Gabmann KG, Rascher W, Hahn EG, Brune K, Dormann H (2008) Women encounter ADRs more often than do men. Eur J Clin Pharmacol 64:999-1004
34. Rodenburg EM, Stricker BHC, Visser LE (2011) Sex-related differences in hospital admissions attributed to adverse drug reactions in Netherlands. Br J Clin Pharmacol 71:95-104
35. Budnitz DS, Loovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365:2002-2012
36. Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc J-L, Lapeyre-Mestre M (2009) Hospitalizations because of adverse drug reactions in elderly patients admitted though the emergency department. A prospective study. Drugs Aging 26:475-482
37. McDonnell J, Jacobs MR (2002) Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36:1331-1336
38. Wu WK, Pantaleo N (2003) Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm 60:253-259
39. Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Saljé K, Mueller S, Hippius N, Thuermann PA, Hasford J, for the Net of Regional Pharmacovigilance Centers (2011) Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf 20:626-634
40. Hofer-Dueckelmann C, Prinz E, Beindi W, Szymanski J, Fellhofer G, Pichler M, Schuler J (2011) Adverse drug reactions (ADRs) associated with hospital admissions - elderly female patients are at higher risk. Int J Clin Pharmacol Ther 49:577-586
41. Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G, Colusso AM, Pacilli L, Pilotto A (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit. A prospective study of 1756 patients. Drug Saf 31:545-556
42. Hartholt KA, van der Velde N, Looman CWN, Panneman MJM, van Beek EF, Patka P, van der Cammen TJM (2010) Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugs. PLoS ONE 5:e13977
43. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Licassen P, Pirmohamed M (2007) Which drugs cause presentable admissions to hospital? A systematic review. Br J Clin Pharmacol 63:136-147
44. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling A-K, Avorn J (2002) Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58:258-291
45. Conforti A, Constantini D, Zanetti F, Moretti U, Grezzana M, Leone R (2012) Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug Healthc Patient Saf 4:75-80
46. Patel KJ, Media MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ (2007) Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol 7:8
47. Hakkarainen KM, Hedna K, Petzold M, Hägg S (2012) Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - A meta-analysis. PLoS ONE 7:e33236